4ZB-21223-98217 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-12-18
Registered in v-safe
2022-12-19
Dose 1 — Moderna
Co-administered: Flu
2022-12-20
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Sleepiness, Irritability/crying

Under 3 check-in
2022-12-21
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-12-22
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Redness, Swelling/hardness · None

Under 3 check-in
2022-12-23
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Swelling/hardness · None

Under 3 check-in
2022-12-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Swelling/hardness · None

Under 3 check-in
2022-12-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-12-26
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-01-02
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-01-10
Survey response — day 21, dose 1, under 3
MedDRA: Nasal congestion, Pyrexia — Feeling: Fair · Be unable to work or attend school

MedDRA releases: 2024-11
2023-01-16
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-01-17
Dose 2 — Moderna
Co-administered: Flu
2023-01-23
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2023-01-26
Health check-in — day 7, dose 2, under 3
Feeling: Good · Sleepiness, Irritability/crying

Under 3 check-in
2023-01-31
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-02-10
Survey response — day 21, dose 2, under 3
MedDRA: Insomnia, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11
2023-02-14
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-02-21
Survey response — day 35, dose 2, under 3
MedDRA: Eye discharge, Nasopharyngitis — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11
2023-03-03
Survey response — day 42, dose 2, under 3
MedDRA: Cough, Diarrhoea, Ear infection, Fatigue, Irritability, Parainfluenzae virus infection, Pyrexia, Rhinorrhoea, Rhinovirus infection, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-03
Report sent to call center — day 42, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-06
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-12-19	Moderna	Flu
2	2023-01-17	Moderna	Flu

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Ear infection	·	·	✓
SD	Eye discharge	·	·	✓
SD	Fatigue	·	·	✓
SD	Insomnia	·	·	✓
SD	Irritability	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Parainfluenzae virus infection	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Rhinovirus infection	·	·	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release